What is RE Botanicals?
RE Botanicals operates at the intersection of premium wellness and sustainable agriculture, specializing in USDA-certified organic CBD products derived from hemp. The company distinguishes itself through a rigorous production process that ensures its tinctures, body oils, and pet-focused solutions remain non-GMO and glyphosate-free. Beyond product quality, the firm maintains a strong commitment to environmental stewardship, notably donating 1% of its sales to support regenerative farming education. This dual focus on consumer health and ecological responsibility has allowed the brand to capture a loyal demographic of health-conscious individuals and pet owners seeking transparent, high-quality hemp-based alternatives.
How much funding has RE Botanicals raised?
RE Botanicals has raised a total of $386K across 2 funding rounds:
Debt
$150K
Debt
$236K
Debt (2020): $150K with participation from PPP
Debt (2021): $236K led by PPP
Key Investors in RE Botanicals
PPP
Public-Private Partnership
What's next for RE Botanicals?
With the recent influx of capital, RE Botanicals is poised to scale its supply chain and deepen its commitment to regenerative agriculture. The company's strategic roadmap likely involves enhancing its distribution channels and investing in R&D to maintain its premium status in an increasingly crowded market. As the regulatory environment for hemp-derived products continues to evolve, the firm's emphasis on certification and sustainable sourcing provides a competitive moat. Future growth will likely center on market penetration and the continued professionalization of its operational infrastructure to support long-term scalability.
See full RE Botanicals company page
